Zobrazeno 1 - 10
of 146
pro vyhledávání: '"E. A. Vasilenko"'
Autor:
T. V. Dubinina, A. M. Lila, E. V. Kvasova, E. M. Agafonova, I. A. Andrianova, L. V. Ivanova, D. V. Yurk, N. A. Garaeva, E. Y. Akulinushkina, A. N. Vedekhina, I. B. Bashkova, S. A. Lapshina, Y. Y. Grabovetskaya, N. F. Semenova, M. I. Valkova, D. G. Krechikova, O. S. Mazhaeva, I. B. Vinogradova, O. V. Bugrova, S. M. Voloshenko, G. R. Enikeeva, E. S. Immis, L. F. Timasheva, E. E. Biserova, L. Z. Shaimukhametova, I. M. Patrikeeva, A. A. Barakat, P. A. Shesternya, N. M. Nikitina, M. I. Yupatova, O. N. Anoshenkova, M. A. Korolev, Y. B. Ubshaeva, E. A. Vasilenko, E. V. Zonova, O. B. Nesmeyanova, E. A. Bogdanova, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko
Publikováno v:
Современная ревматология, Vol 18, Iss 2, Pp 41-50 (2024)
NiSpAR is a non-interventional, multicenter study whose aim was to describe a cohort of patients with non-radiological axial spondyloarthritis (nr-axSpA) and approaches to its diagnosis in the Russian Federation.Material and methods. The study involv
Externí odkaz:
https://doaj.org/article/2a154a8a1e144ba9b91b347f8b742753
Autor:
T. V. Korotaeva, E. E. Gubar, E. Yu. Loginova, Y. L. Korsakova, E. A. Vasilenko, I.-D. Yu. Ilyevsky, L. V. Ivanova, E. Yu. Akulinushkina, P. A. Shesternya, O. V. Matveychuk, Yu. Yu. Grabovetskaya, A. A. Barakat, M. A. Korolev, E. V. Zonova, O. A. Georginova, I. V. Kolotilina, I. M. Marusenko, I. B. Vinogradova, O. B. Nesmeyanova, N. E. Grigoriadi, A. V. Petrov, D. G. Krechikova, T. V. Kropotina, S. P. Yakupova, V. I. Mazurov
Publikováno v:
Современная ревматология, Vol 17, Iss 6, Pp 22-30 (2023)
Psoriatic arthritis (PsA) is a chronic immunoinflammatory disease of the joints, spine and entheses from the group of spondyloarthritis, which is usually observed in patients with psoriasis. In recent years, the axial form of PsA (axPsA) has been act
Externí odkaz:
https://doaj.org/article/2ce507c9aff047a4aa939b461df954ab
Autor:
V. I. Mazurov, A. L. Maslyanskiy, K. E. Zotkina, S. S. Benevolenskaya, D. V. Motorin, A. Yu. Zaritskiy, E. A. Vasilenko, A. A. Vasilenko, A. M. Titova
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 3, Pp 381-387 (2022)
One of the methods of treating severe forms of systemic scleroderma is hematopoietic stem-cell autotransplantation (auto-HSCT). The article describes two clinical cases of auto-HSCT followed by rituximab (RTM) therapy in patients with diffuse systemi
Externí odkaz:
https://doaj.org/article/4634e492ce7a4de98e6bca577f198bdd
Autor:
A. Yu. Popova, E. B. Ezhlova, A. A. Melnikova, V. S. Smirnov, L. V. Lyalina, A. V. Ermakov, N. I. Solomashchenko, I. V. Kovalchuk, E. A. Vasilenko, E. N. Romanenko, A. V. Zvoliborskaya, A. V. Ryabykh, L. I. Dmitrienko, N. A. Mezhlumyan, A. A. Sharova, V. V. Vetrov, A. A. Totolian
Publikováno v:
Журнал инфектологии, Vol 13, Iss 4, Pp 79-89 (2021)
Introduction. The first pandemic in the 21st century, caused by the pathogenic representative of the coronavirus SARS-CoV-2, began in the Chinese city of Wuhan, where the first outbreak of coronavirus pneumonia was recorded in December 2019. The dise
Externí odkaz:
https://doaj.org/article/fd14563540a448ae8a9f4647d2c7e8ea
Autor:
E. E. Gubar, Y. L. Korsakova, E. Yu. Loginova, T. V. Korotaeva, E. A. Vasilenko, A. A. Vasilenko, N. A. Kuznetsova, I. M. Patkikeeva, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 563-570 (2021)
Objective of the study – to compare, in real clinical practice, according to the data of the Russian Psoriatic Arthritis Registry, characteristics of two groups of psoriatic arthritis (PsA) patients: with and without nail psoriasis.Material and met
Externí odkaz:
https://doaj.org/article/dcb2dcf1847a4f338b51d1759ca42b43
Autor:
Yu. L. Korsakova, T. V. Korotaeva, E. Yu. Loginova, E. E. Gubar, E. A. Vasilenko, A. A. Vasilenko, N. A. Kuznetsova, I. M. Patrikeeva, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 275-281 (2021)
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis associated with psoriasis (Ps); it belongs to the group of spondyloarthritis and is accompanied by damage to both the spine and peripheral joints, as well as the development of enter
Externí odkaz:
https://doaj.org/article/83606ec8cd484209863740c428ab24ce
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 6, Pp 658-662 (2021)
IgA anti-CD74 can be a promising marker for diagnosis, assessment of activity and prognosis for ankylosing spondylitis.The aim of the study was to determine the level of IgA anti-CD74 in patients with ankylosing spondylitis and to evaluate its relati
Externí odkaz:
https://doaj.org/article/436e6ebaccd440839be9d6ebcba0030d
Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 165-170 (2020)
Psoriatic arthritis (PsA) is a chronic immune-mediated disease from a group of spondyloarthritis, which is characterized by damage to the musculoskeletal system with a wide range of different clinical manifestations and is usually associated with pso
Externí odkaz:
https://doaj.org/article/b67bf023dea9451998508e22d034103b
Autor:
E. Yu. Loginova, T. V. Korotaeva, Yu. L. Korsakova, E. E. Gubar, P. O. Tremaskina, E. A. Vasilenko, I. N. Kushnir, I. M. Patkikeeva, S. S. Kudishina, P. A. Shesternya, A. V. Petrov, N. A. Kuznetsova, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 14, Iss 3, Pp 19-26 (2020)
Objective: to study the clinical characteristics of PsA and working capacity in patients included in the All-Russian PsA Registry.Patients and methods. The investigation enrolled 614 patients aged 19–84 years with psoriasis from 39 subjects the Rus
Externí odkaz:
https://doaj.org/article/3983e5a5d03c41408a2c61e3cff76c94
Autor:
E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, S. I. Glukhova, E. A. Vasilenko, A. A. Vasilenko, N. A. Kuznetsova, I. M. Patrikeyeva, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 15, Iss 3 (2021)
Objective: to compare the clinical efficacy in real clinical practice of the targeted synthetic disease-modifying antirheumatic drug (sDMARD) tofacitinib (TOFA) and the biologic DMARD (bDMARD), an inhibitor of tumor necrosis factor alpha (TNFα), ada
Externí odkaz:
https://doaj.org/article/a93ceb85d4554e998f0f769a4d919a0f